ARCHIVES

NCI Relates FDA Instructions On Latest IND Delays

This article is from The Cancer Letter archive.

Vol. 02 No. 44 | October 29, 1976

Download PDF Visit The Full Archive

Related Articles

Dasatinib, Nilotinib Show Strong Early Results As Frontline Therapy For CML

December 28, 2007

Proceedings Initiated Against Two Physicians At Dana-Farber

April 7, 1995

Young Reappointed BSA Chairman.

November 30, 2007

NCCS Networker Volume 5 Issue 2, Spring 1991

April 13, 1991

CCRAC Approves New Grant Program For Studies Of Cancer Patient Compliance RFA to Be Issued

May 16, 1980

Study Links Exercise and Survival In Breast and Colon Cancer Mortality

May 25, 2012